Home / Investors Information / EDAP Reports Strong Year-over-Year Revenue Growth in Second Quarter 2015 Read more about EDAP Reports Strong Year-over-Year Revenue Growth in Second Quarter 2015 EDAP Provides Formal Response to FDA Addressing All Concerns Raised in July 2015 Ablatherm HIFU Letter Read more about EDAP Provides Formal Response to FDA Addressing All Concerns Raised in July 2015 Ablatherm HIFU Letter EDAP to Hold Second Quarter 2015 Conference Call on August 27, 2015 Read more about EDAP to Hold Second Quarter 2015 Conference Call on August 27, 2015 EDAP Receives Feedback From FDA on Direct De Novo 510(k) Petition for Ablatherm HIFU Read more about EDAP Receives Feedback From FDA on Direct De Novo 510(k) Petition for Ablatherm HIFU EDAP Names Francois Dietsch Chief Financial Officer Read more about EDAP Names Francois Dietsch Chief Financial Officer EDAP's Focal One(R) HIFU Device Adopted by Two University Hospitals in Switzerland Read more about EDAP's Focal One(R) HIFU Device Adopted by Two University Hospitals in Switzerland EDAP Announces Senior Management Transition Read more about EDAP Announces Senior Management Transition EDAP Announces Focal One(R) HIFU Installation at Germany's Martini-Klinik Read more about EDAP Announces Focal One(R) HIFU Installation at Germany's Martini-Klinik EDAP Reports First Quarter 2015 Results Read more about EDAP Reports First Quarter 2015 Results EDAP to Report First Quarter 2015 Results on May 13, 2015 Read more about EDAP to Report First Quarter 2015 Results on May 13, 2015 Pagination First page « First Previous page ‹ Previous … Page 21 Page 22 Page 23 Page 24 Current page 25 Page 26 Page 27 Page 28 Page 29 … Next page Next › Last page Last » Subscribe to
EDAP Reports Strong Year-over-Year Revenue Growth in Second Quarter 2015 Read more about EDAP Reports Strong Year-over-Year Revenue Growth in Second Quarter 2015
EDAP Provides Formal Response to FDA Addressing All Concerns Raised in July 2015 Ablatherm HIFU Letter Read more about EDAP Provides Formal Response to FDA Addressing All Concerns Raised in July 2015 Ablatherm HIFU Letter
EDAP to Hold Second Quarter 2015 Conference Call on August 27, 2015 Read more about EDAP to Hold Second Quarter 2015 Conference Call on August 27, 2015
EDAP Receives Feedback From FDA on Direct De Novo 510(k) Petition for Ablatherm HIFU Read more about EDAP Receives Feedback From FDA on Direct De Novo 510(k) Petition for Ablatherm HIFU
EDAP Names Francois Dietsch Chief Financial Officer Read more about EDAP Names Francois Dietsch Chief Financial Officer
EDAP's Focal One(R) HIFU Device Adopted by Two University Hospitals in Switzerland Read more about EDAP's Focal One(R) HIFU Device Adopted by Two University Hospitals in Switzerland
EDAP Announces Senior Management Transition Read more about EDAP Announces Senior Management Transition
EDAP Announces Focal One(R) HIFU Installation at Germany's Martini-Klinik Read more about EDAP Announces Focal One(R) HIFU Installation at Germany's Martini-Klinik
EDAP to Report First Quarter 2015 Results on May 13, 2015 Read more about EDAP to Report First Quarter 2015 Results on May 13, 2015
